Newsroom
Cutting-Edge Research. Translational Science.
Presentations
Life Sciences Future
September 25 & 26, 2025
King of Prussia, PA
6th Annual Genome Editing Therapeutics Summit
September 29 - October 1, 2025
Boston, MA
Advanced Therapies USA 2025 Congress
November 18 & 19, 2025
Philadelphia, PA
Scientific Publications
CRISPR gene editing: Can we make cancer cells easier to kill?
Author: Eric B. Kmiec
Journal: Research Outreach (Page 62) 2024
CRISPR-Directed Gene Editing as a Method to Reduce Chemoresistance in Lung Cancer Cells
Authors: Rivera-Torres N, Bialk P, Kmiec EB
Book: Cancer Systems and Integrative Biology, 2023
Authors: Banas K, Modarai S, Rivera-Torres N, Yoo B-C, Bialk P, Barrett C, Batish M, Kmiec EB
Journal: Gene Therapy, 2022Potential Inequities in New Medical Technologies
Authors: Kmiec EB, Marron J
Journal: Scientific American, 2020Authors: Banas K, Rivera-Torres N, Bialk P, Yoo BC, Kmiec EB
Journal: Molecular Cancer Research, 2020Authors: Bialk P, Wang Y, Banas K, Kmiec EB
Journal: Molecular Therapy Oncolytics, 2018
Latest News
CorriXR Therapeutics Appoints Jan Case as Chief Operating Officer
Publication: Business Wire
4 companies to watch in the accelerating gene editing race
Publication: PharmaVoice
CorriXR Therapeutics Names Eric Kmiec Chief Executive Officer
Publication: Business Wire
CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors
Publication: Business Wire
Precision Medicine in Delaware: Working to treat every body according to its genetic makeup
Publication: Delaware Business Times
RealLIST Connectors 2024: Meet 20 of the most impactful leaders in Delaware’s innovation scene
Publication: Technical.ly
CorriXR: How This Company Is Using CRISPR/Cas Gene Editing To Develop New Medicines
Publication: Pulse 2.0
RealLIST Startups 2024: Delaware’s most promising early-stage companies
Publication: Technical.ly

Contact Us
Reach out to discuss partnerships to advance our technology.